Discipline | Medicine |
---|---|
Language | English |
Edited by | John R. Adler, Alexander Muacevic |
Publication details | |
Former name(s) | PeerEMed |
History | 2009–present |
Publisher | |
Frequency | Irregular |
Yes | |
License | CC-BY 4.0 |
1.2 (2022) | |
Standard abbreviations | |
ISO 4 | Cureus |
Indexing | |
ISSN | 2168-8184 |
LCCN | 2012200440 |
Links | |
Cureus:Journal of Medical Science is a web-based peer-reviewed open access general medical journal using postpublication peer review. It is also the first academic journal which provides authors with step-by-step templates for them to use to write their papers. [1] The journal's founding editors-in-chief are John R. Adler (Stanford University) and Alexander Muacevic (University of Munich). [2]
The journal was originally started as PeerEMed in 2009, obtaining its current name in December 2012. [1] Under its system, after an article is published, anyone can review it, but the reviews of experts will be given a higher score. [3] As of December 2022, the journal became part of the Springer Nature group of journals. [4]
The journal has been abstracted and indexed in the Emerging Sources Citation Index. As of October 2024 [update] , the journal's indexation in the Web of Science indices is "on hold" and pending re-evaluation, with the concerns on "the quality of the content published in this journal" being cited as a reason for the suspension. [5]
Its peer-review process involves asking experts to review a given article in a few days, which results in its peer reviews taking much less time than those of most other journals do. [3] Adler told Retraction Watch in 2015 that "Yes Cureus has an unusually fast review process, which is an important part of the journal’s philosophy. We believe that post publication peer review, a focus of our journal through commenting and our unique SIQ process, is potentially a more powerful way to discern truth." [6] Nevertheless, the speed and the quality of this peer review process, as well as the article-level metric "Scholarly Impact Quotient" (SIQ) used by Cureus has attracted the criticism of librarians [7] and scientists who worry that the SIQ could be gamed. [8]
A 2022 study conducted by librarians at Emory University reviewed NIH-funded research publications by Emory faculty over the last five years for work published in potentially predatory publications. The general criteria for assessing a "predatory" or controversial journal included: poor website quality and misleading claims about indexing and impact metrics; lack of transparency regarding peer-review practice expectations; lack of statements affirming adherence to common ethical standards; charges for removal of an article from consideration or for unsolicited copy editing and promises of rapid (within days to weeks rather than months) or guaranteed publication. Of 23,743 articles assessed, 109 were found. Of those, Cureus and Oncotarget together represented 50% of those publications. [9] The study does not specify the exact number from Cureus, nor does it specify precisely how a journal was classified as predatory or not.
Cureus was also criticized for having published a revision of an article that had been elsewhere retracted because of methodological reasons and scrutiny for “possible violations of medical ethics and human rights” (the results of a Covid-19 proxalutamide trial in Brazil). [10]
In April 2022, Cureus displayed a Wall of Shame to "highlight authors who have committed egregious ethical violations as well as the institutions that enabled them". [11] This feature drew criticism as it unjustly put the emphasis on individuals, in particular the corresponding author. This feature was withdrawn in May 2023.
In April 2022, Cureus published notes of concerns relating to nearly 50 papers published without the knowledge of the corresponding author/disputed authorship. In January 2024, 56 papers were retracted. [12]
Scientific misconduct is the violation of the standard codes of scholarly conduct and ethical behavior in the publication of professional scientific research. It is violation of scientific integrity: violation of the scientific method and of research ethics in science, including in the design, conduct, and reporting of research.
In academic publishing, a retraction is a mechanism by which a published paper in an academic journal is flagged for being seriously flawed to the extent that their results and conclusions can no longer be relied upon. Retracted articles are not removed from the published literature but marked as retracted. In some cases it may be necessary to remove an article from publication, such as when the article is clearly defamatory, violates personal privacy, is the subject of a court order, or might pose a serious health risk to the general public.
Hindawi was a publisher of peer-reviewed, open access, scientific journals active in scientific, technical, and medical (STM) literature. It was founded in 1997 in Cairo, Egypt, and purchased in 2021 for $298 million by John Wiley & Sons, a large US-based publishing company.
The Archives of Sexual Behavior is a peer-reviewed academic journal in sexology. It is the official publication of the International Academy of Sex Research.
PLOS One is a peer-reviewed open access mega journal published by the Public Library of Science (PLOS) since 2006. The journal covers primary research from any discipline within science and medicine. The Public Library of Science began in 2000 with an online petition initiative by Nobel Prize winner Harold Varmus, formerly director of the National Institutes of Health and at that time director of Memorial Sloan–Kettering Cancer Center; Patrick O. Brown, a biochemist at Stanford University; and Michael Eisen, a computational biologist at the University of California, Berkeley, and the Lawrence Berkeley National Laboratory.
MDPI is a publisher of open-access scientific journals. It publishes over 390 peer-reviewed, open access journals. MDPI is among the largest publishers in the world in terms of journal article output, and is the largest publisher of open access articles.
Evidence-Based Complementary and Alternative Medicine is a peer-reviewed open-access medical journal covering complementary and alternative medicine published by Hindawi Publishing Corporation.
Virology Journal is an open-access peer-reviewed medical journal published by BioMed Central. It publishes research related to viruses and the prevention of viral infection. The journal was established in 2004 with Robert Garry as founding editor-in-chief and has been edited by Linfa Wang since 2012. It aims to cover rapid communications amongst virologists.
Scientific Research Publishing (SCIRP) is a predatory academic publisher of open-access electronic journals, conference proceedings, and scientific anthologies that are considered to be of questionable quality. As of December 2014, it offered 244 English-language open-access journals in the areas of science, technology, business, economy, and medicine.
Frontiers in Psychology is a peer-reviewed open-access academic journal covering all aspects of psychology. It was established in 2010 and is published by Frontiers Media, a controversial company that is included in Jeffrey Beall's list of "potential, possible, or probable predatory publishers". The editor-in-chief is Axel Cleeremans.
Scientific Reports is a peer-reviewed open-access scientific mega journal published by Nature Portfolio, covering all areas of the natural sciences. The journal was established in 2011. The journal states that their aim is to assess solely the scientific validity of a submitted paper, rather than its perceived importance, significance, or impact.
Retraction Watch is a blog that reports on retractions of scientific papers and on related topics. The blog was launched in August 2010 and is produced by science writers Ivan Oransky and Adam Marcus. Its parent organization is the Center for Scientific Integrity, a US 501(c)(3) nonprofit organization.
Frontiers Media SA is a publisher of peer-reviewed, open access, scientific journals currently active in science, technology, and medicine. It was founded in 2007 by Kamila and Henry Markram. Frontiers is based in Lausanne, Switzerland, with offices in the United Kingdom, Spain, and China. In 2022, Frontiers employed more than 1,400 people, across 14 countries. All Frontiers journals are published under a Creative Commons Attribution License.
Oncotarget is a primarily oncology-focused, peer-reviewed, open access journal. The journal was established in 2010 and is published by Impact Journals. The editors-in-chief are Mikhail Blagosklonny and Andrei V. Gudkov.
Predatory publishing, also write-only publishing or deceptive publishing, is an exploitative academic publishing business model, where the journal or publisher prioritizes self-interest at the expense of scholarship. It is characterized by misleading information, deviates from the standard peer review process, is highly non-transparent, and often utilizes aggressive solicitation practices.
Springer Nature or the Springer Nature Group is a German-British academic publishing company created by the May 2015 merger of Springer Science+Business Media and Holtzbrinck Publishing Group's Nature Publishing Group, Palgrave Macmillan, and Macmillan Education.
Tumor Biology is a bimonthly peer-reviewed open access medical journal covering clinical and experimental oncology. It was established in 1980 as Oncodevelopmental Biology and Medicine, obtaining its current name in 1984. It is owned by the International Society of Oncology and BioMarkers, of which it is the official journal. Originally published by Karger Publishers, it moved to Springer Science+Business Media beginning in 2010. In December 2016, the journal moved again, this time to SAGE Publications. The editor-in-chief is Magdalena Chechlinska. According to the Journal Citation Reports, the journal has a 2016 impact factor of 3.650.
The Indian Journal of Medical Ethics is a quarterly peer-reviewed academic journal covering medical ethics and bioethics. It was established in 1993 by the Forum for Medical Ethics Society, an activist group campaigning to reform the Maharashtra Medical Council. The journal was originally entitled Medical Ethics, and its first issue was published in August 1993. It obtained its current title in January 2004. The editor-in-chief is Amar Jesani. The online version of the journal is open-access, the printed version is subscription-based; there are no article processing charges.
Noora is a COVID-19 vaccine candidate developed by Baqiyatallah University of Medical Sciences in collaboration with Plasma Darman Sarv Sepid Co. in Iran. Introduced in June 2021, it was announced as having "successfully passed the first phase of its clinical trial" two months later.